Study held to see the effect of KULATTHA(HORSE-GRAM)YUSHA in treating Kidney stones

A CLINICAL STUDY TO EVALUATE THE EFFECT OF â??KULATTHA (HORSE-GRAM) YUSHAâ?? INTHE MANAGEMENT OF â??MOOTRASHMARIâ??

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029553

Enrollment

Registered

2020-12-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N201- Calculus of ureter

Interventions

Intervention1: KULATTHA (HORSE-GRAM) YUSHA Group-B(Trial): Administration of 160ml/day KULATTHA (HORSE-GRAM) YUSHA orally in Morning for Breakfast for 20 days along with conventional therapy in Group

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from MOOTRASHMARI only.

Exclusion criteria

Exclusion criteria: . Known patients of Systemic diseases like malignancy, Kochâ??s patients and medico-renal disease (M.R.D.) patient. 2. Known diagnosed patients of Renal failure, congenital disorder like ectopic kidney, horse shoe kidney, stricture at UV and PU junction, neoplasm. 3. Known Patients having severe Hydronephrosis/more than mild to moderate (i.e. Grade 4 of Hydronephrosis).

Design outcomes

Primary

Measure	Time frame
A known diagnosed case having Ureteric calculus 5mm to 8mm of Age group 18 to 60 years with irrespective of gender will be selected and Diagnosis will be established on the basis of Investigation USG Abdomen and Pelvis Urine-routine and Microscopic and Haemogram before and after treatment to assess the outcomes primary secondary and final on the basis of time duration of treatmentTimepoint: Kulattha Yusha will be given as a treatment for mootrashmari on first day of trial along with Follow up for day 7th day 14th and 20th day will be taken	—

Measure

Time frame

A known diagnosed case having Ureteric calculus 5mm to 8mm of Age group 18 to 60 years with irrespective of gender will be selected and Diagnosis will be established on the basis of Investigation USG Abdomen and Pelvis Urine-routine and Microscopic and Haemogram before and after treatment to assess the outcomes primary secondary and final on the basis of time duration of treatmentTimepoint: Kulattha Yusha will be given as a treatment for mootrashmari on first day of trial along with Follow up for day 7th day 14th and 20th day will be taken

—

Secondary

Measure	Time frame
Diagnosis will be established on the basis of Investigation USG (Abdomen & Pelvis,Urine-routine-& Microscopic and Haemogram before and after treatment assessed on the basis of Udarshool (Pain in Abdomen site & intensity) As per visual analogue scale (V.A.S.) Sadaha mootra pravrutti (Burning Micturition) {Presence of Pus cell in Urine(R)} Sarakta Mootra Pravrutti (Presence of RBCâ??s in Urine) Size of Ashmari Numbers of Ashmari Site of Ashmari Timepoint: 20 days(0,7,14,20)	—

Measure

Time frame

Diagnosis will be established on the basis of Investigation USG (Abdomen & Pelvis,Urine-routine-& Microscopic and Haemogram before and after treatment assessed on the basis of Udarshool (Pain in Abdomen site & intensity) As per visual analogue scale (V.A.S.) Sadaha mootra pravrutti (Burning Micturition) {Presence of Pus cell in Urine(R)} Sarakta Mootra Pravrutti (Presence of RBCâ??s in Urine) Size of Ashmari Numbers of Ashmari Site of Ashmari Timepoint: 20 days(0,7,14,20)

—

Countries

India

Contacts

Public ContactUrmila J Shirke

Dr. D. Y. Patil College of Ayurved and Research Centre

drujshirke@gmail.com9850769938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026